Sector revisions Ipsen Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 02:17:14 2026-08-10 EDT			5-day change	1st Jan Change
161.20 ^EUR	+0.12%		-1.41%	+35.80%

08-04	Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration	CI
08-03	Jefferies Downgrades Ipsen to Underperform, Boosts PT	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Nbr of analysts
IPSEN	-	-	-	-	-	-
ELI LILLY AND COMPANY						27
JOHNSON & JOHNSON						22
ABBVIE INC.						28
ROCHE HOLDING AG						18
NOVARTIS AG						21
ASTRAZENECA PLC						22
AMGEN INC.						29
NOVO NORDISK A/S						24
GILEAD SCIENCES, INC.						27
PFIZER INC.						26
BRISTOL-MYERS SQUIBB COMPANY						24
VERTEX PHARMACEUTICALS INCORPORATED						25
GSK PLC						20
SANOFI						23
CHUGAI PHARMACEUTICAL CO., LTD.						15
BAYER AG						18
TAKEDA PHARMACEUTICAL COMPANY LIMITED						16
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD						15
HALEON PLC						17
Average						22
Weighted average by Cap.						24